NIH launches partnership to improve success of clinical trials for patients with Parkinson’s disease
Effort is part of the Accelerating Medicines Partnership to speed development of disease-altering treatments.

The National Institutes of Health is teaming with government, biopharmaceutical, life science and non-profit organizations to overcome obstacles and increase success for advancing promising treatments for Parkinson’s disease (PD). Part of the NIH Accelerating Medicines Partnership (AMP), AMP PD will focus on identifying and validating promising markers of disease called biomarkers that may be useful in tracking the progression of PD and could serve as biological targets for the development of new drugs.

Related posts:

  1. Medicare Card, Researchers examine how Parkinson’s disease alters brain activity over time Medicare Card, Researchers examine how Parkinson’s disease alters brain activity over time...
  2. Medicare Card, Researchers find a gap in the brain’s firewall against Parkinson’s disease Medicare Card, Researchers find a gap in the brain’s firewall against Parkinson’s disease...
  3. Medicare, study finds two pesticides associated with Parkinson’s disease Medicare, NIH study finds two pesticides associated with Parkinson's disease...
  4. Medicare Card, Waterlogged brain region helps scientists gauge damage caused by Parkinson’s disease Medicare Card, Waterlogged brain region helps scientists gauge damage caused by Parkinson’s disease...
  5. Medicare, Deep Brain Stimulation, Two Different Targets, Produces Similar Motor Improvements in Parkinson’s Disease In a major study, investigators have compared how individuals with Parkinson’s disease respond to deep brain stimulation (DBS) at two different sites in the brain. Contrary to current belief, patients who received DBS at either site in the brain experienced comparable benefits for the motor symptoms of Parkinson’s....
  6. Medicare Card, NIH-led effort launches Big Data portal for Alzheimer’s drug discovery Medicare Card, NIH-led effort launches Big Data portal for Alzheimer’s drug discovery...
  7. Patient-derived stem cells could improve drug research for Parkinson’s Researchers have taken a step toward personalized medicine for Parkinson’s disease, by investigating signs of the disease in patient-derived cells and testing how the cells respond to drug treatments. The study was funded by the National Institutes of Health....
  8. Protein linked to Parkinson’s disease may regulate fat metabolism National Institutes of Health researchers have found that Parkin, an important protein linked with some cases of early-onset Parkinson’s disease, regulates how cells in our bodies take up and process dietary fats....
  9. Medicare Card, Researchers make advance in possible treatments for Gaucher, Parkinson’s diseases Medicare Card, Researchers make advance in possible treatments for Gaucher, Parkinson’s diseases...
  10. Medicare Card, Immune system may mount an attack in Parkinson’s disease Medicare Card, Immune system may mount an attack in Parkinson’s disease...
  11. Medicare Card, NIH researchers use brain imaging to understand genetic link between Parkinson’s and a rare disease Medicare Card, NIH researchers use brain imaging to understand genetic link between Parkinson’s and a rare disease...
  12. Medicare Card, New evidence that viruses may play a role in Alzheimer’s disease Medicare Card, New evidence that viruses may play a role in Alzheimer’s disease...
  13. Medicare Card, Protein affected by rare Parkinson’s mutation Medicare Card, Protein affected by rare Parkinson’s mutation...
  14. Researchers Identify Gene Mutations Underlying Risk for Most Common Form of Parkinson’s Disease Parkinson's disease, which affects about 1.5 million Americans, is a progressive neurologic disorder caused by the degeneration of nerve cells in the portion of the brain that controls movement....
  15. Medicare Card, International diabetes research knowledge portal opens to public, scientists Medicare Card, International diabetes research knowledge portal opens to public, scientists...